Orthobiologics

OSTEOGROW, an EU-funded collaborative research project, is investigating a new bone regeneration therapy based on autologous blood + BMP-6 for use...

RTI Surgical received regulatory clearance for nanOss® Bioactive bone void filler in Australia, as well as CE Mark for nanOss Bioactive Loaded and...

Bioventus commenced U.S. launch of GELSYN-3™ three-injection hyaluronic acid for relief of pain associated with knee osteoarthritis....

BONESUPPORT received FDA approval to launch an Investigational Device Exemption study of CERAMENT G bone graft substitute in the treament of open diaphyseal tibial...

Vertical Spine achieved a milestone with the 1,000th case performed using its FIBRINET® System for the generation of Platelet-Rich Fibrin...

Orthofix launched the PHOENIX® Minimally Invasive Spinal Fixation system in Japan....

Pluristem Therapeutics intends to conduct a U.S./EU Phase III trial assessing use of PLX-PAD (PLacental eXpanded) cells to support recovery following surgery...

Data from a 12-month study of 1-level ACDF patients treated with Trinity Evolution® + a PEEK interbody spacer demonstrated fusion rates of...

Xtant Medical has more than doubled the capacity of its tissue processing facility in Montana with the addition of seven new...

Pre-clinical studies suggest that multipotent adult progenitor cells (MAPCs), such as the technology used in RTI Surgical’s map3® Cellular Allogeneic Bone Grafts, exhibited...